Methods and compositions for modulating beta chain mediated immunity

Abstract

The present disclosure relates to bispecific molecules targeting Vβ17 and DLL3, nucleic acids and expression vectors encoding said molecules, recombinant cells containing the vectors, and compositions comprising the molecules. Methods of making the antibodies, and methods of using the antibodies to kill cancer cells, are also provided.